More than 1.5 billion adults and almost 400 million children one in every four people in the world will be living with obesity within 12 years, if the condition isn't stopped.
If nothing changes, the economic impact of obesity in the world will reach $4.32 trillion in losses annually by 2035, due to medical expenses, absenteeism from work, low productivity, premature retirement and death. This figure represents almost 3% of current global GDP, comparable to the impact of the Covid-19 pandemic in 2020.
Pharmaceutical companies have done big business when it comes to tackling unhealthy body weight. These firms have now turned the fight against obesity into their latest boon. The condition of obesity is believed to be the largest biopharmaceutical market of the decade, with Goldman Sachs estimating a potential turnover of $100 billion annually by 2030.
[
add
]
[
|
|
...
]